
Learn the Excision of synovial chondromatosis using a posterior approach to the knee surgical technique with step by step instructions on OrthOracle. Our e-learning platform contains high resolution images and a certified CME of the Excision of synovial chondromatosis using a posterior approach to the knee surgical procedure.
Primary synovial chondromatosis is a benign, metaplastic and chondrogenic disorder of the synovium most commonly involving the knee, in two-thirds of cases, of middle aged patients. Extra-articular synovial chondromatosis may occasionally be encountered in hand and feet. Symptoms include firm articular swellings, which my be painful or associated with mechanical locking, restriction or crepitus. Radiographs and CT highlight small rounded calcifications at the periphery of the joint. The standard initial treatment for symptomatic patients includes joint-preserving arthroscopic or open resection by way of synovectomy. Incomplete removal will likely result in local recurrence, reported in up-to 25% cases. If asymptomatic, clinical and radiological surveillance may be acceptable to both patient and surgeon.
Secondary synovial chondromatosis, characterised by loose bodies within degenerative synovial joints, is associated with degenerative joint disease for which the management is the same as the primary aetiology i.e. non-operative management of osteoarthritis prior to joint replacement surgery.
Rarely, secondary synovial chondrosarcoma has been reported to arise in primary synovial chondromatosis; symptom progression over several months (82%), rapid recurrence after complete resection (30%), and medullary canal invasion (43%) are associated with malignant change (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481616/).
When there is anxiety regarding diagnosis, disease extent or malignant transformation, referral to a specialist orthopaedic oncology centre may be preferred, but the majority of cases can be managed in non-oncology units.
Author : Mr Jonathan Stevenson FRCS (Tr & Orth).
Institution: The Royal Orthopaedic hospital, Birmingham, UK.
Clinicians should seek clarification on whether any implant demonstrated is licensed for use in their own country.
In the USA contact: fda.gov
In the UK contact: gov.uk
In the EU contact: ema.europa.e

Indications:
Relative indications for surgical excision of primary synovial chondromatosis include pain, swelling and mechanical symptoms such as stiffness or locking from the effected joint. An absolute indication for surgery is evidence of malignant transformation to secondary chondrosarcoma. Symptomatically this is suggested by sudden symptom onset, rapid recurrence after primary treatment and radiographically evidence of medullary canal invasion.
Symptoms in clinical assessment:
Routine examination of the knee may identify an effusion and restriction of the joint (as in this case, with limited knee flexion beyond 80 degrees) and a bony hard mass at the posterior aspect of the knee in the popliteal fossa. Clinical assessment should also include neurovascular assessment distally to compare to post-operatively.
Investigations:
Patients have plain radiographs which may show synovial based masses with ‘popcorn-like’ calcifications and bone erosions in almost 50% of cases. MRI is routinely undertaken to delineate the exact location of the synovial masses and their anatomical relationships to neurovascular structures. The calcifications are represented by a signal void on the MR imaging. Benign & malignant synovial chondromatosis share non-specific features including soft tissue mass, joint effusion, joint space destruction, osseous erosion and local recurrence. Concerning features include large size, rapid clinical progression of pain, local recurrence within 12 months after complete resection, soft-tissue infiltration and invasion of the medullary canal (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481616/).
Operative alternatives:
If the patient is asymptomatic and there are no imaging characteristics suggestive of malignancy, observation alone may be sufficient. For discrete lesions of the anterior knee, hip and shoulder arthroscopic resection may be feasible; in the present case the patient had already undergone a complete open anterior synovectomy and now warranted open posterior capsular synovectomy due to the extent of disease.
Contraindications:
Contraindications for surgery include medical co-morbidities deeming general anaesthesia unsafe.


Distal neurovascular observations post-operatively (motor and sensory function and vascular status of the limb distally to be documented)
24-hours of IV antibiotics (Flucloxacillin)
VTE: early mobilisation protective weight bearing with crutches and mechanical thrombo prophylaxis with foot pumps and TED stockings for six weeks, chemical thrombo prophylaxis with low molecular weight Heparin from six hours post-operatively for two weeks.
Removal of clips at 14 days
Outpatient physiotherapy aiming to achieve 90o flexion within five days

This patient was walking without pain nor analgesia with improved range of motion and return to work by six weeks post-operatively. Local recurrence is associated with incomplete excision and occurs in up-to 25% of cases. Consequently post-operative surveillance for recurrence should involve clinical and radiological review for several years post-operatively.
Synovial chondromatosis can rarely undergo a malignant transformation. There are a limited number of case reports, since this was first reported in 1957. However, about half were reported to be high grade and half low grade and associated with a 30% risk of recurrence arising in the knee (50%), hip (33%), ankle (6%) and shoulder (4%). Multiple surgeries have been described, culminating in amputation in 61% of cases. Pre-operatively, malignant transformation is suggested by a rapid recurrence after previous resection and invasion of the medullary canal on imaging (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481616/).
In 2017 The Mayo Clinic, Rochester, described the outcomes of 20 patients who underwent total knee replacements for synovial chondromatosis. Five patients suffered recurrence and were treated with further synovectomy and revision surgery or amputation in three of those five. There was a high risk of complications with knee replacement with this condition including stiffness in 45% and amputation in 10% and revision in 15% (https://www.sciencedirect.com/science/article/pii/S0883540317301584).
Reference
- orthoracle.com


























